Abstract 4325: FXYD5 plays diverse roles in immune evasion and tumor progression in prostate cancer
Ru Wen(Stratford University), James D. Brooks(Cancer Research Institute), Fernando Jose Garcia Marques(Canary Institute of Cancer Research), Nathan Lam(Stratford University), Aram Lyu(Fred Hutch Cancer Center), Guillem Pratx(Stratford University), Lawrence Fong(University of California, San Francisco), Zenghua Fan(University of California, San Francisco), Hongjuan Zhao(Stratford University), Abel Bermudez(Canary Institute of Cancer Research), Eric E. Peterson(Stratford University), Donna M. Peehl(City College of San Francisco), Zhengyuan Qiu(Stratford University), Sharon J. Pitteri, Gerald E. Marti, Neeladrisingha Das(Stratford University)
Cited by 1
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
How many human proteoforms are there?
|Nature Chemical Biology|2018|942